Posted by Michael Wonder on 30 Aug 2022
Rafa receives FDA approval for life-saving midazolam auto-injector
30 August 2022 - The first in market product was developed in cooperation with the US Department of Defense.
Rafa Laboratories is pleased to announce the US FDA has approved its first in market 10 mg midazolam auto-injector for the treatment of status epilepticus in adults.
